UCB Japan Co. Ltd.
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- Subsidiary
- Established
- 1988-04-28
- Employees
- 501
- Market Cap
- -
- Website
- http://www.ucbjapan.com
A Long Term Follow up Administration Study of L059 (Levetiracetam) in Epilepsy Patients With Partial Onset Seizures
- First Posted Date
- 2006-08-22
- Last Posted Date
- 2020-11-13
- Lead Sponsor
- UCB Japan Co. Ltd.
- Target Recruit Count
- 398
- Registration Number
- NCT00367432
Maintenance Study of Certolizumab Pegol (CZP) in Crohn's Disease
- First Posted Date
- 2006-05-24
- Last Posted Date
- 2015-03-18
- Lead Sponsor
- UCB Japan Co. Ltd.
- Target Recruit Count
- 40
- Registration Number
- NCT00329550
A Double-blind Confirmatory Trial of Levetiracetam in Epilepsy Patients With Partial Onset Seizures
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2006-01-23
- Last Posted Date
- 2015-02-11
- Lead Sponsor
- UCB Japan Co. Ltd.
- Target Recruit Count
- 352
- Registration Number
- NCT00280696
Follow-up Study of L059 (Levetiracetam) in Epileptic Patients With Partial Onset Seizures by Open Label Method
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2019-06-10
- Lead Sponsor
- UCB Japan Co. Ltd.
- Target Recruit Count
- 154
- Registration Number
- NCT00160615
© Copyright 2024. All Rights Reserved by MedPath